Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.

Abstract

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 30-JUN 03, 2014